Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1274029

IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE


Linarić, Petra; Pavlović Mavić, Mirjana; Mirčevski, Karla; Meštrović, Josipa; Jakšić, Petra; Tečić Vuger, Ana; Vazdar, Ljubica; Šeparović, Robert
IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE // Libri Oncologici
Zagreb, 2023. str. 68-69 (poster, domaća recenzija, sažetak, stručni)


CROSBI ID: 1274029 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE

Autori
Linarić, Petra ; Pavlović Mavić, Mirjana ; Mirčevski, Karla ; Meštrović, Josipa ; Jakšić, Petra ; Tečić Vuger, Ana ; Vazdar, Ljubica ; Šeparović, Robert

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni

Izvornik
Libri Oncologici / - Zagreb, 2023, 68-69

Skup
16th Croatian oncology congress

Mjesto i datum
Poreč, Hrvatska, 20.04.2023. - 23.04.2023

Vrsta sudjelovanja
Poster

Vrsta recenzije
Domaća recenzija

Ključne riječi
HER2 positive breast cancer, dual anti-HER2 blockade, immunohistochemistry

Sažetak
Results of our research showed that there was no statistically significant difference in duration of treatment between patients with luminal and non-luminal subtype, same as was reported in CLEOPATRA trial. Analyzing correlation between duration of treatment and HER2 receptor expression, there was no statistically significant difference between subgroups with 3+ and 2+ expression. This was not concordant with referent trial results, which have shown shorter progression free survival in subgroup with lower HER2 receptor expression (2+), without impact on overall survival.

Izvorni jezik
Engleski



POVEZANOST RADA


Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada

Citiraj ovu publikaciju:

Linarić, Petra; Pavlović Mavić, Mirjana; Mirčevski, Karla; Meštrović, Josipa; Jakšić, Petra; Tečić Vuger, Ana; Vazdar, Ljubica; Šeparović, Robert
IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE // Libri Oncologici
Zagreb, 2023. str. 68-69 (poster, domaća recenzija, sažetak, stručni)
Linarić, P., Pavlović Mavić, M., Mirčevski, K., Meštrović, J., Jakšić, P., Tečić Vuger, A., Vazdar, L. & Šeparović, R. (2023) IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE. U: Libri Oncologici.
@article{article, author = {Linari\'{c}, Petra and Pavlovi\'{c} Mavi\'{c}, Mirjana and Mir\v{c}evski, Karla and Me\v{s}trovi\'{c}, Josipa and Jak\v{s}i\'{c}, Petra and Te\v{c}i\'{c} Vuger, Ana and Vazdar, Ljubica and \v{S}eparovi\'{c}, Robert}, year = {2023}, pages = {68-69}, keywords = {HER2 positive breast cancer, dual anti-HER2 blockade, immunohistochemistry}, title = {IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE}, keyword = {HER2 positive breast cancer, dual anti-HER2 blockade, immunohistochemistry}, publisherplace = {Pore\v{c}, Hrvatska} }
@article{article, author = {Linari\'{c}, Petra and Pavlovi\'{c} Mavi\'{c}, Mirjana and Mir\v{c}evski, Karla and Me\v{s}trovi\'{c}, Josipa and Jak\v{s}i\'{c}, Petra and Te\v{c}i\'{c} Vuger, Ana and Vazdar, Ljubica and \v{S}eparovi\'{c}, Robert}, year = {2023}, pages = {68-69}, keywords = {HER2 positive breast cancer, dual anti-HER2 blockade, immunohistochemistry}, title = {IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE}, keyword = {HER2 positive breast cancer, dual anti-HER2 blockade, immunohistochemistry}, publisherplace = {Pore\v{c}, Hrvatska} }




Contrast
Increase Font
Decrease Font
Dyslexic Font